BCYC
Bicycle Therapeutics PLC
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No N-PORT holders.
—
Bicycle Therapeutics PLC
3.65
No thesis.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Baker Bros. AdvisorsBaker Bros. | $46.2M | 28.87% | 0.00% | |
| 2 | Fcpm III Services B.V.Fcpm III Services B.V. | $14.7M | 9.20% | 0.00% | |
| 3 | Armistice CapitalArmistice Capital | $14.4M | 9.01% | 0.00% | |
| 4 | Long Focus Capital ManagementLong Focus | $14.0M | 8.78% | 0.00% | |
| 5 | Acadian Asset ManagementAcadian | $8.3M | 5.22% | 0.00% | |
| 6 | Renaissance TechnologiesRenaissance Technologies | $6.5M | 4.07% | +56.58% | |
| 7 | GlaxosmithklineGlaxosmithkline | $6.5M | 4.06% | 0.00% | |
| 8 | T. Rowe Price AssociatesT. Rowe Price | $3.8M | 2.39% | −12.26% | |
| 9 | Marshall WaceMarshall Wace | $3.4M | 2.12% | +111.47% | |
| 10 | Qube Research & TechnologiesQube Research & Technologies | $3.3M | 2.06% | +151.30% | |
| 11 | Morgan StanleyMorgan Stanley | $2.8M | 1.77% | +7.92% | |
| 12 | Citadel AdvisorsCitadel | $2.7M | 1.66% | +52.85% | |
| 13 | Schroder Investment Management GroupSchroder | $2.6M | 1.60% | 0.00% | |
| 14 | Millennium ManagementMillennium | $2.3M | 1.47% | +95.07% | |
| 15 | Peapod Lane CapitalPeapod Lane Capital | $2.3M | 1.43% | +344.22% | |
| 16 | Diadema PartnersDiadema Partners | $2.0M | 1.23% | −2.88% | |
| 17 | Jane Street GroupJane Street | $1.9M | 1.21% | +50.08% | |
| 18 | Two Sigma InvestmentsTwo Sigma | $1.8M | 1.15% | +163.70% | |
| 19 | Susquehanna International GroupSusquehanna International | $1.5M | 0.93% | +18.72% | |
| 20 | Birchview CapitalBirchview Capital | $1.3M | 0.83% | −32.35% | |
| 21 | BlackRockBlackRockindex-like | $1.2M | 0.74% | +0.50% | |
| 22 | Moore Capital ManagementMoore | $1.2M | 0.73% | 0.00% | |
| 23 | Rangeley CapitalRangeley Capital | $1.1M | 0.67% | +9.14% | |
| 24 | Palo Alto InvestorsPalo Alto Investors | $856,014 | 0.54% | 0.00% | |
| 25 | OZ ManagementOZ Management | $839,113 | 0.52% | new |
103 managers report $159.9M of Bicycle Therapeutics on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; Baker Bros. is largest at 28.87%.
Expected move
No implied move.